Skip to content

Clinical trials

Phase 4 Schizophrenia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 4 Country / region: Canada Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20052
20063
20081
20091
20131
20141
20151
20161
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Terminated3
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health5
University of British Columbia3
Hamilton Health Sciences Corporation2
Janssen-Ortho Inc., Canada2
Université de Montréal2
Eli Lilly and Company1
Northwell Health1
Ortho-McNeil Janssen Scientific Affairs, LLC1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
St. Joseph's Healthcare Hamilton1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia19
Psychotic Disorders8
Weight Gain2
Bipolar Disorder1
Cognition Disorders1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Metabolic Syndrome1
Schizophrenia Spectrum and Other Psychotic Disorders1
Substance-Related Disorders1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.